Abstract Details

Title The Role of Discharge Disposition in the Interventional Management of Stroke (IMSIII) Trial

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) (-)

Poster/Presentation
Number 062

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Samir Belagaje, MD, FAAN (Dept of Neurology Emory University) PRESENTER	Dr. Belagaje has nothing to disclose.
Rishi Gupta, MD	No disclosure on file
Julia Tsai (Marinus Pharmaceuticals, Inc)	No disclosure on file
	No disclosure on file
Brett M. Kissela, MD, MS, FAAN (University of Cincinnati Hospital)	The institution of Dr. Kissela has received research support from NIH/NINDS. Dr. Kissela has a non-compensated relationship as a Board Member with AHA Regional Board that is relevant to AAN interests or activities.
Joseph P. Broderick, MD, FAAN (University of Cincinnati)	The institution of Dr. Broderick has received research support from Novo Nordisk. Dr. Broderick has received publishing royalties from a publication relating to health care.

��ɫ����